Aspirin may cut mortality in nonmetastatic prostate cancer

October 24, 2014
Aspirin may cut mortality in nonmetastatic prostate cancer

(HealthDay)—Daily aspirin use, even at low doses, may reduce mortality among men with high-risk nonmetastatic prostate cancer, according to research published online Oct. 20 in the Journal of Clinical Oncology.

Eric J. Jacobs, Ph.D., of the American Cancer Society in Atlanta, and colleagues analyzed data for men diagnosed with nonmetastatic prostate cancer to assess the association between daily aspirin use and prostate cancer-specific mortality (PCSM). The men were enrolled in the Cancer Prevention Study-II Nutrition Cohort between 1992 or 1993 and June 2009, and followed up through 2010.

The researchers found that, after multivariable adjustment, neither prediagnosis (hazard ratio [HR], 0.92; 95 percent confidence interval [CI], 0.72 to 1.17) nor postdiagnosis (HR, 0.98; 95 percent CI, 0.74 to 1.29) daily use of aspirin showed a statistically significant association with PCSM compared with no aspirin use. Among men diagnosed with high-risk cancers (≥T3 and/or Gleason score ≥8), postdiagnosis daily aspirin use was associated with lower PCSM (HR, 0.60; 95 percent CI, 0.37 to 0.97). In this subgroup, no difference in risk was observed according to aspirin dose, such as the typical low dose of 81 mg per day (HR, 0.50; 95 percent CI, 0.27 to 0.92) or higher doses (HR, 0.73; 95 percent CI, 0.40 to 1.34).

"A randomized trial of among men diagnosed with nonmetastatic was recently funded," the authors write. "Our results suggest any additional randomized trials addressing this question should prioritize enrolling men with high-risk cancers and need not use high doses."

One author disclosed financial ties to Bayer.

Explore further: Aspirin may lower the risk for aggressive prostate cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Aspirin may lower the risk for aggressive prostate cancer

September 30, 2014
Use of aspirin and/or other non-steroidal anti-inflammatory drugs (NSAIDs) was associated with a reduced risk for aggressive prostate cancer in men who had elevated prostate specific antigen (PSA) and a negative biopsy prior ...

Study identifies low-dose aspirin's mechanisms of action in reducing cancer mortality

September 30, 2014
Low-dose aspirin may lower the risk for cancer metastasis and mortality by inhibiting both COX-1 and COX-2 pathways, according to data presented at the 13th Annual AACR International Conference on Frontiers in Cancer Prevention ...

Report says new evidence could tip the balance in aspirin cancer prevention care

April 9, 2012
A new report by American Cancer Society scientists says new data showing aspirin's potential role in reducing the risk of cancer death bring us considerably closer to the time when cancer prevention can be included in clinical ...

Job strain can raise risk of developing type 2 diabetes

August 4, 2014
(HealthDay)—Stress at work may increase the risk of developing type 2 diabetes, according to research published in the August issue of Diabetes Care.

Chemo rx patterns changed before reimbursement changes

October 8, 2014
(HealthDay)—Other factors may affect chemotherapy prescription patterns more than changes in Medicare reimbursement, according to a study published online Sept. 29 in the Journal of Clinical Oncology.

Recommended for you

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Study finds gut microbiome can control antitumor immune function in liver

May 24, 2018
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published May 25 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.